Whitehawk Therapeutics, Inc.
WHWK
$3.92
$0.123.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.60M | -15.62M | -10.42M | 27.61M | -63.69M |
| Total Depreciation and Amortization | 79.00K | 125.00K | 167.00K | 200.00K | 193.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.85M | -78.66M | -78.49M | -79.01M | 10.00M |
| Change in Net Operating Assets | 1.93M | -1.10M | -6.82M | -563.00K | -6.05M |
| Cash from Operations | -97.43M | -95.25M | -95.56M | -51.76M | -59.55M |
| Capital Expenditure | -552.00K | -738.00K | -926.00K | -1.47M | -1.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 101.29M | 101.29M | 101.36M | 101.36M | -- |
| Other Investing Activities | -88.84M | -92.37M | 4.46M | 30.26M | 26.86M |
| Cash from Investing | 11.89M | 8.18M | 104.89M | 130.15M | 25.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.08M | 100.10M | 100.10M | 100.17M | 146.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.70M | -5.70M | -5.70M | -4.83M | -16.00K |
| Cash from Financing | 94.38M | 94.40M | 94.40M | 95.34M | 130.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.83M | 7.33M | 103.73M | 173.73M | -34.22M |